PMC:7594251 / 44561-44818
Annnotations
LitCovid-PD-MONDO
| Id | Subject | Object | Predicate | Lexical cue | mondo_id |
|---|---|---|---|---|---|
| T34 | 122-125 | Disease | denotes | STD | http://purl.obolibrary.org/obo/MONDO_0021681 |
LitCovid-PD-CLO
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T304 | 60-63 | http://purl.obolibrary.org/obo/CLO_0051582 | denotes | has |
| T305 | 253-255 | http://purl.obolibrary.org/obo/CLO_0050160 | denotes | T2 |
LitCovid-PD-CHEBI
| Id | Subject | Object | Predicate | Lexical cue | chebi_id |
|---|---|---|---|---|---|
| T434 | 253-255 | Chemical | denotes | T2 | http://purl.obolibrary.org/obo/CHEBI_29298|http://purl.obolibrary.org/obo/CHEBI_75710 |
LitCovid-sentences
| Id | Subject | Object | Predicate | Lexical cue |
|---|---|---|---|---|
| T311 | 0-86 | Sentence | denotes | Ligand-based screening, the second approach of NMR in FBDD, has three main categories: |
| T312 | 87-257 | Sentence | denotes | 1) Saturation Transfer Difference (STD) and Nuclear Overhauser Effect (NOE) type methods, based on 2) diffusion methods, or 3) relaxation-based methods (i.e., T1 and T2). |